AXA S.A. - TEVA PHARMACEUTICAL FIN LLC ownership

Quarter-by-quarter ownership
AXA S.A. ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q2 2020$13,396,000
+4.6%
13,832,0000.0%0.03%
-18.8%
Q1 2020$12,802,000
-2.4%
13,832,0000.0%0.03%
+18.5%
Q4 2019$13,112,000
+4.7%
13,832,0000.0%0.03%
+8.0%
Q3 2019$12,524,000
-51.8%
13,832,000
-51.3%
0.02%
-51.0%
Q2 2019$25,968,000
+85.3%
28,400,000
+86.8%
0.05%
-7.3%
Q1 2019$14,013,000
+2.2%
15,200,0000.0%0.06%
-8.3%
Q4 2018$13,718,000
-3.5%
15,200,0000.0%0.06%
+15.4%
Q3 2018$14,216,000
+0.9%
15,200,0000.0%0.05%
-3.7%
Q2 2018$14,089,000
+5.8%
15,200,0000.0%0.05%
+1.9%
Q1 2018$13,322,000
-56.9%
15,200,000
-56.8%
0.05%
-56.2%
Q4 2017$30,888,000
-13.9%
35,200,000
-11.6%
0.12%
-21.9%
Q3 2017$35,870,000
-25.3%
39,800,000
-11.2%
0.16%
-28.9%
Q2 2017$48,048,000
+11.9%
44,800,000
+12.0%
0.22%
+12.4%
Q1 2017$42,950,000
-1.9%
40,000,0000.0%0.19%
-5.8%
Q4 2016$43,800,000
+8.0%
40,000,000
+17.6%
0.21%
+15.7%
Q3 2016$40,566,000
+10.5%
34,000,000
+16.0%
0.18%
+8.5%
Q2 2016$36,717,000
-3.7%
29,300,0000.0%0.16%
-4.1%
Q1 2016$38,127,000
-16.7%
29,300,0000.0%0.17%
-14.5%
Q4 2015$45,745,000
+34.9%
29,300,000
+17.2%
0.20%
+43.9%
Q3 2015$33,906,000
-3.0%
25,000,0000.0%0.14%
-0.7%
Q2 2015$34,938,000
+18.0%
25,000,000
+25.0%
0.14%
+14.8%
Q1 2015$29,600,00020,000,0000.12%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q3 2023
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders